Cryosite Limited

CTE

AU000000CTE1

Healthcare Facilities & Services

Market Closed - Australian S.E. Other stock markets 11:01:08 2024-09-17 pm EDT			5-day change	1st Jan Change
0.8000 ^AUD	+5.96%		+6.67%	+32.23%

10:04am	Cryosite Limited Announces Company Secretary Changes	CI
Aug. 20	Cryosite Limited Announces Retirement of John Hogg as Chief Executive Officer, Effective October 31, 2024	CI

Ex-dividend day

February 20, 2024

A dividend is removed today from 's share.

Latest news about Cryosite Limited

Cryosite Limited Announces Company Secretary Changes	04:04am	CI
Cryosite Limited Announces Retirement of John Hogg as Chief Executive Officer, Effective October 31, 2024	Aug. 20	CI
Cryosite Limited Appoints Andrew Kerr as Executive Director	Aug. 20	CI
Cryosite Limited Reports Earnings Results for the Full Year Ended June 30, 2024	Aug. 20	CI
Cryosite Limited Declares Dividend for Full Year 2024, Payable in October 2024	Aug. 20	CI
Cryosite Limited Announces Retirement of Andrew Kroger from the Board of Directors	Jun. 25	CI
Cryosite Limited Announces Board Changes	Feb. 22	CI
Cryosite Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 22	CI
Cryosite Proposes Capital Return to Shareholders	Jan. 04	MT
Cryosite Limited Announces Director Changes	Dec. 07	CI
Cryosite Limited Announces Dividend for the Twelve Months Ended June 30, 2023, Payable on October 6, 2023	23-08-24	CI
Cryosite Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-24	CI
Cryosite Limited Appoints Luis Antonio as an Independent Non-Executive Director	23-04-16	CI
Cryosite Limited Announces the Resignation of Bryan Dulhunty as Non Executive Director	23-02-28	CI
Cryosite Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-23	CI
Cryosite Limited Announces Change of Company Secretary	23-01-17	CI
Cryosite Limited Announces Ordinary Dividend for the Year Ended June 30, 2022, Payable on October 14, 2022	22-08-25	CI
Cryosite Limited Reports Earnings Results for the Full Year Ended June 30, 2022	22-08-25	CI
Cryosite Limited Announces Board Changes	22-03-09	CI
Cryosite Limited Reports Earnings Results for the Half Year Ended December 31, 2021	22-02-22	CI
Cryosite Limited Announces Change in Company Secretary	22-01-10	CI
Cryosite Limited Appoints Steven Waller as Non-Executive Director	21-11-18	CI
Cryosite Limited Reports Earnings Results for the Full Year Ended June 30, 2021	21-08-24	CI
Tranche Update on Cryosite Limited's Equity Buyback Plan announced on March 11, 2021.	21-05-17	CI
Cryosite Limited's Equity Buyback announced on March 11, 2021, has expired with 0 shares, representing 0% for AUD 0 million.	21-05-16	CI

Cryosite Limited is engaged in providing outsourced clinical trials depot services. The Company manages the entire clinical trial supply chain from importation, receipt, specialized ambient, cold, frozen, and liquid nitrogen storage for temperature-sensitive products, distribution and reverse logistics management. Its segments include Clinical trials and biological services logistics and Cord Blood and tissue storage. The Clinical trials and biological services logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns, biological services and cell gene therapies depot services. Cord Blood and tissue storage segment provides storage of cord blood and tissue samples. Its facilities are purpose-built to store a range of biological materials, including Cell Banks (MCB, WCB), Mesenchymal Stromal Cell (MSC) Therapies, Tumour-Infiltrating Lymphocyte Therapies and others.

Employees

Sector

Healthcare Facilities & Services

Calendar

2025-02-19 - Q2 2025 Earnings Release (Projected)

More about the company